External Doctoral Candidate
Sara Gehder (formerly: Dühnen)
Room: D 3.014
Phone: +49 (0) 40 42878 4237
E-Mail: sara.gehder@tuhh.de
To arrange an appointment, please contact us by e-mail.
Curriculum vitae
01/2023 - Today
|
PhD Student - Data Driven Innovation in Healthcare, Technische Universität Hamburg
|
01/2023 - Today
|
Unternehmensentwicklung - Digital Office, Die Techniker Krankenkasse
|
02/2022 - 01/2023
|
Head of Business Development & Partnerships, Kry
|
02/2021 - 01/2022
|
Business Development, Kry
|
02/2019 - 12/2020
|
Consultant, Roland Berger
|
10/2018 - 12/2018
|
Intern Business Consulting, Bayer Business Services
|
04/2018 - 09/2018
|
Research Associate, Humboldt-Universität zu Berlin
|
08/2017 - 10/2017
|
Intern, Roland Berger
|
06/2016 - 07/2017
|
Freelancer - Technology Office Chemicals Science Relations, Merck KGaA
|
03/2016 - 06/2016
|
Intern Technology Office, Merck KGaG
|
07/2016 - 10/2016
|
Research Associate, Cornell University
|
2016 - 2018
|
Master of Science (M.Sc.) - Molecular Life Sciences, Humboldt-Universität zu Berlin
|
05/2015 - 12/2015
|
Research Associate, Universidad de los Andes, Bogotá
|
08/2014 - 10/2014
|
Research Internship, Freie Universität Berlin
|
2013 - 2016
|
Bachelor of Science (B.Sc.) - Biology, Freie Universität Berlin
|
2012 - 2014
|
Project Manager, LBBW
|
2009 - 2012
|
Bachelor of Arts (BA) - Business Administration, Duale Hochschule Baden-Württemberg
|
Research interests
Sara Gehder's research focuses on advancing the integration of patient-centered digital health applications into healthcare delivery. Her work explores innovative approaches to evidence generation, with particular emphasis on real-world data (RWD) and its potential to demonstrate the effectiveness of mHealth applications in improving care. Sara is also deeply interested in the regulatory and implementation frameworks that facilitate the adoption of digital health solutions, such as Germany's Fast-Track Approval Process for Digital Health Applications (DiGA) under the Digital Healthcare Act. Her current projects investigate the use of RWD to capture the nuanced impact of mHealth interventions, addressing challenges in transitioning from traditional evidence models like randomized controlled trials to more dynamic and continuous performance monitoring. Additionally, she explores the broader conceptualization of efficacy, examining how patient-relevant structural and procedural improvements can drive healthcare innovation. Through this work, Sara investigates barriers to the adoption of patient-centered digital health solutions and identifies pathways to facilitate their inclusion in statutory healthcare systems worldwide.